Ertapenem Sodium Salt: Applied Workflows for Resistance Research

Principle Overview: Harnessing Ertapenem for Contemporary Microbiology

In the era of escalating antibiotic resistance, Ertapenem (sodium salt) stands out as a robust, broad-spectrum carbapenem antibiotic for research against diverse Gram-positive and Gram-negative pathogens. As a potent penicillin-binding protein inhibitor, Ertapenem demonstrates rapid bactericidal action via inhibition of PBPs, particularly PBPs 2 and 3 in Escherichia coli, thus disrupting bacterial cell wall synthesis (source: product_spec). Recent high-impact studies on carbapenem-resistant Enterobacter cloacae (CREC) have highlighted the relevance of Ertapenem in dissecting resistance gene transmission and multidrug resistance dynamics, especially in clinical isolates where carbapenemase-encoding genes (CEGs) predominate (source: paper).

For translational researchers, APExBIO's Ertapenem sodium salt offers exceptional solubility in water (≥52 mg/mL), low MIC₉₀ values for Enterobacteriaceae (<1 mg/L), and stability under controlled conditions—making it an ideal antibacterial agent for Gram-positive and Gram-negative bacteria in both phenotypic assays and molecular studies (source: product_spec).

Step-by-Step Workflow: Designing Resistance and Susceptibility Assays

Implementing Ertapenem sodium salt into laboratory assays follows a sequence designed for reproducibility and mechanistic clarity:

1. Preparation and Storage: Dissolve Ertapenem sodium salt directly in sterile water to prepare stock solutions at concentrations up to 52 mg/mL. Store aliquots at -20°C and use within 24 hours post-dilution for maximal potency (source: product_spec).
2. MIC Determination: Employ the broth microdilution method to establish MIC₉₀ values for target strains. For most Enterobacteriaceae, expect MIC₉₀ < 1 mg/L, enabling precise discrimination between susceptible and resistant isolates (source: product_spec).
3. Resistance Modeling: Integrate Ertapenem into time-kill or serial passage experiments to track the emergence of resistance, especially in the presence of plasmid-borne CEGs such as bla_NDM-1 or bla_IMP. Use validated clinical or environmental isolates for maximum translational relevance (source: paper).
4. Pharmacokinetic Profiling: Simulate in vivo pharmacokinetics by adjusting concentration and exposure time in vitro, leveraging Ertapenem’s 3.8–4.4 h plasma half-life and 45% renal clearance to model clinical dosing scenarios (source: product_spec).

Protocol Parameters

• assay | 1–52 mg/mL (stock solution concentration) | MIC testing, time-kill studies | Ensures solubility and accurate dosing; above 52 mg/mL may precipitate | product_spec
• incubation temperature | 35–37°C | Broth microdilution, resistance selection | Mimics physiological conditions for optimal bacterial growth and accurate susceptibility readout | paper
• exposure duration | 18–24 hours | MIC determination, resistance evolution | Standardized duration for endpoint assessment; allows detection of slow-growing resistant subpopulations | workflow_recommendation

Key Innovation from the Reference Study

The recent Guangdong multi-hospital study (2022–2024) delivers several breakthroughs for antibiotic resistance research (source: paper):

• High prevalence (85.19%) of CEGs—particularly bla_NDM-1—in carbapenem-resistant Enterobacter cloacae, with frequent plasmid-mediated transmission and multidrug resistance.
• Demonstrated that the resistance rate to multiple antibiotics (including imipenem and ceftazidime/avibactam) is significantly higher in CEG-positive strains.
• Plasmid conjugation experiments showed a 95.65% success rate in transferring CEGs, underscoring the urgency of tracking horizontal gene transfer.

Practical translation: For assay design, this means Ertapenem sodium salt should be used alongside genetic screening for CEGs, and experiments should include both chromosome- and plasmid-harboring isolates to fully capture resistance dynamics. When studying emerging resistance, pair Ertapenem exposure with PCR or sequencing analysis to monitor gene transfer events and resistance phenotype shifts.

Advanced Applications and Comparative Advantages

Ertapenem sodium salt’s unique pharmacokinetics and spectrum enable advanced experimental designs:

• Modeling Multidrug Resistance: Use in combination assays to evaluate bacterial responses to Ertapenem versus other carbapenems or cephalosporins, directly reflecting clinical co-resistance patterns (source: paper).
• Resistance Gene Transmission Studies: Given the high conjugation rates of bla_NDM-1 and bla_IMP, Ertapenem-containing selection plates are highly effective for isolating and quantifying transfer events (source: paper).
• Pharmacological Modeling: Reproduce human pharmacokinetics in vitro due to Ertapenem’s long plasma half-life and predominant renal elimination, which is especially useful for dose-response and toxicity testing (source: product_spec).

Interlinking Related Insights: The article Ertapenem Sodium Salt: Advances in Translational Resistance Research complements these applications by offering strategic guidance for resistance modeling and pharmacokinetics, while Ertapenem sodium salt: Mechanisms, Resistance, and Research Applications provides foundational detail on Ertapenem’s antibacterial mechanisms. These resources collectively extend the scope from molecular mechanisms to actionable lab protocols, reinforcing APExBIO’s leadership in research reagent quality.

Troubleshooting & Optimization Tips

• Solubility Challenges: If Ertapenem sodium salt appears turbid or precipitates at higher concentrations, confirm the use of sterile water, and avoid ethanol or DMSO unless ultrasonic assistance is available (source: product_spec).
• Rapid Activity Loss: Prepare fresh solutions for each experiment and avoid repeated freeze-thaw cycles to maintain antibiotic potency (source: product_spec).
• Heterogeneous Resistance Detection: When low-level resistance is suspected, extend incubation to 24 h and supplement with PCR-based detection of CEGs for a comprehensive view (workflow_recommendation).
• False Susceptibility: Ensure correct inoculum density and media pH; incorrect conditions can artificially lower MIC readings (workflow_recommendation).

Future Outlook: Implications for Translational Microbiology

The integration of Ertapenem sodium salt into resistance research is poised to accelerate understanding of multidrug resistance and gene transmission, especially as new CEG subtypes emerge. The reference study’s revelation of high conjugation rates for key resistance genes underscores the need for ongoing surveillance and innovative assay design (source: paper). As next-generation sequencing and multiplex PCR become standard, Ertapenem-based assays will remain pivotal for correlating genotype and phenotype in the treatment of bacterial infections.

For those seeking validated, high-purity reagents, APExBIO’s Ertapenem sodium salt continues to set the benchmark in antibacterial research, supporting both foundational studies and advanced translational workflows.